The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid
Open accessAbstract
In spite of the development and wide use of antibiotics, pneumonia is still the leading cause of infection-related mortality worldwide (101), and antibiotic resistance in the major pathogens of pneumonia has become more frequent during the past several decades. In order to defeat and prevent antibiotic resistance, antibiotics need to be used based on pharmacokinetics (PK) and pharmacodynamics (PD) (6, 10, 35). With regard to the PK/PD of antibiotics, considerable effort has been devoted to directly measure the concentrations of antibiotics at infection sites, because the distributions of antibiotics may be different among a variety of tissues. However, even beyond the fact that these measurements are carried out in normal tissues, the techniques used for the measurement are variable in accuracy and reproducibility and the interpretation of their results is hindered by many confounding factors (74, 75). For pulmonary infections, concentrations of antibiotics in epithelial lining fluid (ELF) for extracellular pathogens and in alveolar macrophage (AM) cells for intracellular pathogens are thought to reflect antibiotic activity in pneumonia. Antibiotics whose concentrations are high at these extravascular sites, such as macrolides and fluoroquinolones, tend to be promoted for treatment of pulmonary infection over antibiotics like betalactams and aminoglycosides, even though clinical trials do not show differences in clinical outcome or even bacteriological response. In fact, it is less clear why the ratios of ELF to plasma concentrations are diverse between antibiotics and even between members of the same antibiotic class. The measured ELF-to-plasma concentration ratios may differ based on physicochemical characteristics intrinsic to the molecules. And also, as the ELF concentration of antibiotics is commonly measured by bronchoalveolar lavage (BAL), technical factors or errors in the method of measurement may create these differences. It is believed that these factors need to be clarified before the concept of ELF concentration should be connected to antibiotic outcomes such as bacterial eradication or clinical response. In the current review, data from published human studies were extracted and analyzed to interpret ELF concentrations of antibiotics measured by BAL, considering possible confounding factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
Principles and Practice of Infectious Diseases.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-1-169_2 · Cited by 1,564
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
Rennard, S. I., Basset, G., Lecossier, D., O'Donnell, K. M., Pinkston, P., Martin, P. G., & Crystal, R. G. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.2.532 · Cited by 1,131
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Self-citationClarke's analysis of drugs and poisons
Moffat, A., Osselton, M. D., & Widdop, B. (2003) · Pharmaceutical Press eBooks · Cited by 941
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847
(2012) · Sarcoidosis · doi:10.1201/b13322-18 · Cited by 828
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
The pharmacokinetics of azithromycin in human serum and tissues
Foulds, G., Shepard, R. M., & Johnson, R. B. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.73 · Cited by 755
Cell number and cell characteristics of the normal human lung.
Crapo, J. D., Barry, B. E., Gehr, P., Bachofen, M., & Weibel, E. R. (1982) · PubMed · doi:10.1164/arrd.1982.125.6.740 · Cited by 738
Alavijeh, M. S., Chishty, M., Qaiser, M. Z., & Palmer, A. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.4.554 · Cited by 497
In silico prediction of blood–brain barrier permeation
Clark, D. E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02827-7 · Cited by 483
Computational approaches to the prediction of the blood–brain distribution
Norinder, U., & Haeberlein, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00005-4 · Cited by 305
Lamer, C., de Beco, V, Soler, P., Calvat, S., Fagon, J. Y., Dombret, M. C., Farinotti, R., Chastre, J., & Gibert, C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.281 · Cited by 297
Ball, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.31 · Cited by 290
Cell size of alveolar macrophages: an interspecies comparison.
Krombach, F., Münzing, S., Allmeling, A. M., Gerlach, J. T., Behr, J., & Dörger, M. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51261 · Cited by 285
The structure of the choroid plexus and the physiology of the choroid plexus epithelium
REDZIC, Z., & SEGAL, M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.005 · Cited by 257
DEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITY
Liu, X., Tu, M., Kelly, R. S., Chen, C., & Smith, B. J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.1.132 · Cited by 244
Blood-neural Barrier: Intercellular Communication at Glio-Vascular Interface
Kim, J.-H., Kim, J.-H., Park, J.-A., Lee, S.-W., Kim, W.-J., Yu, Y.-S., & Kim, K.-W. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.4.339 · Cited by 218
Clinical Pharmacokinetics of Clarithromycin
Rodvold, K. A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937050-00003 · Cited by 214
Marcy, T. W., Merrill, W. W., Rankin, J. A., & Reynolds, H. Y. (1987) · American Review of Respiratory Disease · doi:10.1164/arrd.1987.135.6.1276 · Cited by 205
Tissue-directed pharmacokinetics
Schentag, J. J., & Ballow, C. H. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90394-d · Cited by 200
Self-citationRodvold, K. A., Gotfried, M. H., Danziger, L. H., & Servi, R. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1399 · Cited by 200
Hammarlund-Udenaes, M., Paalzow, L. K., & de Lange, E. C. M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012080106490 · Cited by 177
Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response
Nix, D. E., Goodwin, S. D., Peloquin, C. A., Rotella, D. L., & Schentag, J. J. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.10.1953 · Cited by 176
Self-citationComparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin
Patel, K. B., Xuan, D., Tessier, P. R., Russomanno, J. H., Quintiliani, R., & Nightingale, C. H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2375 · Cited by 172
Volume and osmotic properties of human neutrophils
Ting-Beall, H., Needham, D., & Hochmuth, R. (1993) · Blood · doi:10.1182/blood.v81.10.2774.2774 · Cited by 172
Bronchoscopic diagnosis of pneumonia
Baselski, V. S., & Wunderink, R. G. (1994) · Clinical Microbiology Reviews · doi:10.1128/cmr.7.4.533 · Cited by 171
Boselli, E., Breilh, D., Rimmelé, T., Djabarouti, S., Toutain, J., Chassard, D., Saux, M.-C., & Allaouchiche, B. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000168206.59873.80 · Cited by 164
Drug Delivery Across the Blood-Brain Barrier
Chen, Y., Dalwadi, G., & Benson, H. (2004) · Current Drug Delivery · doi:10.2174/1567201043334542 · Cited by 162
Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems
Bodor, N. S., & Buchwald, P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00090-8 · Cited by 161
BARRIER MECHANISMS IN THE BRAIN, I. ADULT BRAIN
Saunders, N., Habgood, M., & Dziegielewska, K. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.02986.x · Cited by 161
Bioavailability and Transport of Peptides and Peptide Drugs into the Brain
Egleton, R. D., & Davis, T. P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00242-8 · Cited by 153
Graff, C. L., & Pollack, G. M. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489126 · Cited by 147
Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning
Nix, D. E., Goodwin, S., Peloquin, C. A., Rotella, D. L., & Schentag, J. J. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.10.1947 · Cited by 144
Self-citationSkeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
Greenspan, S. L., Greenspan, F. S., Resnick, N. M., Block, J. E., Friedlander, A. L., & Genant, H. K. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90066-7 · Cited by 143
Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide
Ackermann, G., & Rodloff, A. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg123 · Cited by 136
Determinants of Passive Drug Entry into the Central Nervous System
Habgood, M. D., Begley, D. J., & Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007001923498 · Cited by 131
Wise, R. A. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.1.1 · Cited by 129
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin
Conte, J. E., Golden, J. A., Duncan, S., McKenna, E., & Zurlinden, E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.334 · Cited by 108
Boyce, J. M., Medeiros, A. A., Papa, E. F., et al. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.1.73 · Cited by 106
Segel, G., Cokelet, G., & Lichtman, M. A. (1981) · Blood · doi:10.1182/blood.v57.5.894.894 · Cited by 103
Validity of Markers of Dilution in Small Volume Lung Lavage
Dargaville, P. A., South, M., Vervaart, P., & McDOUGALL, P. N. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9811049 · Cited by 103
Strazielle, N., Khuth, S. T., & Ghersi‐Egea, J. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.006 · Cited by 98
Re-evaluating current antibiotic therapy
Craig, W. A. (2001) · Respiratory Medicine · doi:10.1016/s0954-6111(01)90023-x · Cited by 91
Pharmacokinetic Considerations in the Treatment of CNS Tumours
Motl, S. E., Zhuang, Y., Waters, C. M., & Stewart, C. F. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00002 · Cited by 77
Computational models to predict blood–brain barrier permeation and CNS activity
Subramanian, G., & Kitchen, D. B. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/b:jcam.0000017372.32162.37 · Cited by 75
Bronchopulmonary Disposition of the Ketolide Telithromycin (HMR 3647)
Muller‐Serieys, C., Soler, P., Cantalloube, C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3104-3108.2001 · Cited by 68
Effects of Gender, AIDS, and Acetylator Status on Intrapulmonary Concentrations of Isoniazid
Conte, J. E., Golden, J. A., McQuitty, M., Kipps, J., Duncan, S., McKenna, E., & Zurlinden, E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2358-2364.2002 · Cited by 65
Jarvis, B., & Lamb, H. M. (1998) · Drugs · doi:10.2165/00003495-199856040-00008 · Cited by 59
Ricci, M., Blasi, P., Giovagnoli, S., & Rossi, C. R. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777452461 · Cited by 56
Nau, R., Sörgel, F., & Prange, H. W. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90052-3 · Cited by 51
Conte, J. E., Golden, J. A., Kipps, J., McIver, M., & Zurlinden, E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3823-3827.2004 · Cited by 40
Grigg, J., Kleinert, S., Woods, R. L., Thomas, C. J., Vervaart, P., Wilkinson, J. L., & ROBERTSON, C. F. (1996) · European Respiratory Journal · doi:10.1183/13993003/erj.9.7.1381 · Cited by 23
Cited by
Tissue Penetration of Antifungal Agents
Felton, T., Troke, P. F., & Hope, W. W. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-13 · Cited by 426
Orally administered amoxicillin/clavulanate: current role in outpatient therapy
Veeraraghavan, B., Bakthavatchalam, Y. D., & Sahni, R. D. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00374-7 · Cited by 44
Metadata
- Authors
- Kiem, S., & Schentag, J. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-01
- Volume
- 52
- Issue
- 1
- Pages
- 24-36
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2112694597
- Cited by
- 289
- References
- 55
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.